Outstanding progress regarding the pathophysiology of Crohn's disease (CD) has led to the development of innovative therapeutic concepts. Numerous controlled trials have been performed in CD. This review concentrates on the results of randomized, placebo-controlled trials, and meta-analyses when available, that provide the highest degree of evidence. Current guidelines on the management of CD recommend a step-up approach to treatment involving the addition of more powerful therapies as the severity of disease and refractoriness to therapy increase. The advent of biological drugs has opened new therapeutic horizons for treating CD, modifying the treatment goals. However, the large majority of patients with CD will be managed through conventional therapy, even if they are a prelude to biological therapy.

Gionchetti P, Calabrese C, Tambasco R, Brugnera R, Straforini G, Liguori G, et al. (2011). Role of conventional therapies in the era of biological treatment in Crohn's disease. WORLD JOURNAL OF GASTROENTEROLOGY, 17(14), 1797-1806 [10.3748/wjg.v17.i14.1797].

Role of conventional therapies in the era of biological treatment in Crohn's disease.

GIONCHETTI, PAOLO;CALABRESE, CARLO;TAMBASCO, ROSY;BRUGNERA, RAMONA;STRAFORINI, GIULIA;LIGUORI, GIUSEPPINA;SPURI FORNARINI, GIULIA;RISO, DONATELLA;CAMPIERI, MASSIMO;RIZZELLO, FERNANDO
2011

Abstract

Outstanding progress regarding the pathophysiology of Crohn's disease (CD) has led to the development of innovative therapeutic concepts. Numerous controlled trials have been performed in CD. This review concentrates on the results of randomized, placebo-controlled trials, and meta-analyses when available, that provide the highest degree of evidence. Current guidelines on the management of CD recommend a step-up approach to treatment involving the addition of more powerful therapies as the severity of disease and refractoriness to therapy increase. The advent of biological drugs has opened new therapeutic horizons for treating CD, modifying the treatment goals. However, the large majority of patients with CD will be managed through conventional therapy, even if they are a prelude to biological therapy.
2011
Gionchetti P, Calabrese C, Tambasco R, Brugnera R, Straforini G, Liguori G, et al. (2011). Role of conventional therapies in the era of biological treatment in Crohn's disease. WORLD JOURNAL OF GASTROENTEROLOGY, 17(14), 1797-1806 [10.3748/wjg.v17.i14.1797].
Gionchetti P; Calabrese C; Tambasco R; Brugnera R; Straforini G; Liguori G; Fornarini GS; Riso D; Campieri M; Rizzello F.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/102967
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact